List view / Grid view
30 April 2015 | By Victoria White
CoLucid Pharmaceuticals has announced that the first patient has been randomised in its SAMURAI study, the Company’s Phase 3 pivotal trial of lasmiditan...
30 April 2015 | By Victoria White
The FDA has accepted for filing and review the sBLA for Opdivo for the treatment of previously untreated patients with unresectable or metastatic melanoma...
29 April 2015 | By kdm communications
Glass Solutions has launched a range of jacketed reactor systems combining excellent value with reliable performance for process development, reaction optimization, or production applications...
29 April 2015 | By Victoria White
amp biosimilars has announced Professor Dr Rolf G. Werner is to head up the Scientific Board as "Chairman of the Scientific Board", effective immediately...
29 April 2015 | By Victoria White
The FDA has granted Fast Track designation for the development of Genzyme’s GZ/SAR402671, an investigational substrate reduction therapy for Fabry disease...
29 April 2015 | By Victoria White
Results from Phase 3 clinical studies of Zerbaxa in complicated urinary tract infections and complicated intra-abdominal infections have been published...
29 April 2015 | By Victoria White
The EC has granted marketing authorisation in Europe for Sanofi’s Toujeo for the treatment of type 1 and type 2 diabetes mellitus in adults...
29 April 2015 | By Victoria White
A survey has revealed there are major gaps in actions needed across all six WHO regions to reduce spread of antibiotic resistance...
29 April 2015 | By Victoria White
A recent survey has found that 52% of 275 ACS patients who were currently taking an oral antiplatelet have missed taking or changed the way they take it...
28 April 2015 | By Victoria White
TxCell has appointed Stéphane Boissel as CEO. In addition, Dr. Miguel Forte, previously SVP Clinical and Regulatory, has been promoted to COO...
28 April 2015 | By Victoria White
Open-label trial shows electroCore’s nVNS therapy does not cause any meaningful cardiovascular adverse effects in patients with asthma...
28 April 2015 | By Victoria White
Mylan has announced that its Board of Directors has unanimously rejected the unsolicited expression of interest from Teva to acquire the Company...
27 April 2015 | By Victoria White
Three posters on the Extended Spectrum Pleuromutilins (ESP) Programme and one poster on lefamulin were presented at ECCMID 2015...
Thermo Fisher Scientific Inc., the world leader in serving science, is unveiling new bioprocessing technologies to address the evolving needs for enhancing the efficiency and productivity of global biopharmaceutical manufacturers. These advancements include single-use systems, purification, cell culture media, analytical systems, adherent cell culture, customized fluid transfer systems and laboratory…
27 April 2015 | By
The European Society of Clinical Microbiology and Infectious Disease (ESCMID) has issued a special excellence award to Médecins Sans Frontières...
